The FTSE 100 enjoyed another leap towards record territory as the index pushed around 0.7 per cent higher on Tuesday, ...

Japan's genome editing market, valued at USD 1.45 billion by 2033, grows at a 17.97% CAGR, driven by precision medicine and biotech investment. Key t ...

Each Option is exercisable for up to five years at a price of $0.70 per share and shall vest in equal parts every six months over the next three years. About Rakovina Therapeutics Inc.

It also heralded a change in strategy, with CEO Robert Davis saying that the company is undergoing "a multiyear optimization ...

Investors were clearly impressed by the company's second-quarter beats, especially the one on the bottom line.

Shares of Novo Nordisk skidded on Tuesday as the Danish drugmaker reduced its expectations on wildly popular drugs Ozempic ...

FDA’s latest whitepaper shows how scalable quality management investments in pharma reduce costs, improve reliability, and ...

Consumers are already stretched thin, so rate cuts may not significantly boost spending or spark runaway inflation as many ...

Novo Nordisk just lost $100 billion in market value. Here's what the crash means for ResMed — and why investor sentiment may ...

"The Mounjaro (tirzepatide) Patient Information Leaflet warns that hair loss is a common side effect in patients treated with ...

Merck & Co. Inc. (NYSE:MRK) shares fell over 6% in early trading Tuesday after the pharmaceutical giant reported a mixed ...

The 15 percent tariff rate agreed under the new deal could significantly impact pharma firms reliant on European imports.